Search research articles
Contact Us
Filters
Showing results (711-720 of 897) with videos related to
Page
of 90
Sort By:
Nature Medicine
|
April 15, 2026
Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes
Chenyu Li, Shola M Richards, Ghazal Quinn, et al.
Circulation. Cardiovascular Genetics
|
February 10, 2011
Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol
Andrew C Edmondson, Peter S Braund, Ioannis M Stylianou, et al.
Circulation Research
|
April 24, 2015
Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease
Hanrui Zhang, Chenyi Xue, Rhia Shah, et al.
Clinical Pharmacology and Therapeutics
|
June 3, 2025
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program
Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.
The Journal of Clinical Investigation
|
May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 22, 2015
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Rachana Shah, Gregory J Matthews, Rhia Y Shah, et al.
Nature Genetics
|
June 18, 2021
A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts
Yogasudha Veturi, Anastasia Lucas, Yuki Bradford, et al.
Journal of Lipid Research
|
February 8, 2017
A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans
Marina Cuchel, Anna C Raper, Donna M Conlon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 12, 2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
Gissette Reyes-Soffer, John S Millar, Colleen Ngai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 28, 2020
Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report
Aeron M Small, Jennifer E Huffman, Derek Klarin, et al.
Page
of 90
Search research articles
Search
Showing results (711-720 of 897) with videos related to
Sort By:
Page
of 90
Nature Medicine
|
April 15, 2026
Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes
Chenyu Li, Shola M Richards, Ghazal Quinn, et al.
Circulation. Cardiovascular Genetics
|
February 10, 2011
Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol
Andrew C Edmondson, Peter S Braund, Ioannis M Stylianou, et al.
Circulation Research
|
April 24, 2015
Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease
Hanrui Zhang, Chenyi Xue, Rhia Shah, et al.
Clinical Pharmacology and Therapeutics
|
June 3, 2025
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program
Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.
The Journal of Clinical Investigation
|
May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 22, 2015
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Rachana Shah, Gregory J Matthews, Rhia Y Shah, et al.
Nature Genetics
|
June 18, 2021
A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts
Yogasudha Veturi, Anastasia Lucas, Yuki Bradford, et al.
Journal of Lipid Research
|
February 8, 2017
A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans
Marina Cuchel, Anna C Raper, Donna M Conlon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 12, 2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
Gissette Reyes-Soffer, John S Millar, Colleen Ngai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 28, 2020
Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report
Aeron M Small, Jennifer E Huffman, Derek Klarin, et al.
Page
of 90